Kolexia
Le Lez Marie-Laure Ophtalmologie
Le Lez Marie-Laure
Ophtalmologie
Centre hospitalier de Tours
Tours, France
58 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Uvéite Lymphome intraoculaire Rétinopathies Oedème maculaire Tumeurs de la rétine Oedème Hémorragie de la rétine Maladies de la choroïde

Collaborateurs

Voir plus
Pisella Pierre-Jean
Pisella Pierre-Jean
Centre hospitalier de Tours, Tours, France
Precausta Flavien
Precausta Flavien
Cabinet libéral, Langeais, France
Khanna Raoul
Khanna Raoul
Centre hospitalier de Tours, Tours, France
Halfon Jeremie
Halfon Jeremie
Cabinet libéral, Chambray-lès-Tours, France

Industries

Voir plus
Bayer
13 collaboration(s)
Dernière en 2023
Novartis
12 collaboration(s)
Dernière en 2023
Allergan
2 collaboration(s)
Dernière en 2022
Horus
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Highly Sensitive Interleukin Score for Intra-Ocular Lymphoma Diagnosis: Evidence from Analysis of 5-Year Real-Life of Use
65th ASH Annual Meeting Abstracts   02 novembre 2023
Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Diabetic Macular Oedema: the ILUVI1MOIS Study.
Ophthalmology and therapy   27 juin 2023
Impact of the French 2020 COVID-19 lockdown on the treatment and follow-up of patients with exudative age-related macular degeneration.
Journal francais d'ophtalmologie   27 mai 2023
Management of binocular diplopia in the department of ophthalmic emergencies at the Regional University Hospital of Tours.
Journal francais d'ophtalmologie   05 avril 2023
TRIOZ: Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema
Essai Clinique (CHU Nantes)   05 septembre 2022
A Rare Case of Didanosine-Induced Mid-Peripheral Chorioretinal Atrophy Identified Incidentally 11 Years after the Drug Cessation.
Medicina (Kaunas, Lithuania)   30 mai 2022
iLOC: Phase II Study of Ibrutinib in Patients With Relapsed or Refractory Primary Central Nervous Lymphoma or Intraocular Lymphoma
Essai Clinique (The Lymphoma Academic Research Organisation)   06 avril 2022
Management of ocular toxoplasmosis in France: Results of a modified Delphi study.
Journal francais d'ophtalmologie   30 janvier 2022
ETOILE: Real-World Evidence of 24 Months of Ranibizumab 0.5 mg in Patients with Visual Impairment Due to Diabetic Macular Edema.
Clinical ophthalmology (Auckland, N.Z.)   03 juin 2021
Intravenous high-dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study.
American journal of hematology   03 mai 2021